Musings on Guidelines and Evidence: A Pragmatic and Nephrocentric View

Jindal K. , Chan C.T. , Deziel C. , Hirsch D. , Soroka S.D. , Tonelli M. Management of blood pressure in hemodialysis patients. J Am Soc Nephrol 2006; 17(3 Suppl 1): S8–10.

Jindal K. , Chan C.T. , Deziel C. , Hirsch D. , Soroka S.D. , Tonelli M. Hemodialysis adequacy in adults. J Am Soc Nephrol 2006; 17(3 Suppl 1): S4–S7.

Jindal K. , Chan C.T. , Deziel C. , Hirsch D. , Soroka S.D. , Tonelli M. Frequent and sustained hemodialysis. J Am Soc Nephrol 2006; 17(3 Suppl 1): S24–7.

Jindal K. , Chan C.T. , Deziel C. , Hirsch D. , Soroka S.D. , Tonelli M. Vascular access. J Am Soc Nephrol 2006; 17(3 Suppl 1): S16–23.

Jindal K. , Chan C.T. , Deziel C. , Hirsch D. , Soroka S.D. , Tonelli M. Mineral metabolism. J Am Soc Nephrol 2006; 17(3 Suppl 1): S11–15.

Jindal K. , Chan C.T. , Deziel C. , Hirsch D. , Soroka S.D. , Tonelli M. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006; 17(3 Suppl 1): S1–27.

Vaage-Nilsen O. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure, part III.2: Treatment of anaemia with iron. Nephrol Dial Transplant 2005; 20: 1512–13.

Locatelli F. , Aljama P. , Bar any P. , Canaud B. , Carrera F. , Eckardt K.U. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19(Suppl 2): ii1–47.

CARI (Caring for Australians with Renal Impairment) Guidelines; 2006. Available at: http://www.cari.org.au/ckd_prevent_list_published.php

Chronic kidney disease in adults: UK guidelines for identification, management and referral of adults. 10-6-2005. Available at: http://www.renal.org/CKDguide/full/Intro.htm

[No authors listed.] I. NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: Update 2000 [Published erratum appears in Am J Kidney Dis 2005; 45: 791]. Am J Kidney Dis 2001; 37(1 Suppl 1): S7–64.

[No authors listed.] II. NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: Update 2000. Am J Kidney Dis 2001; 37(1 Suppl 1): S65–136.

[No authors listed.] III. NKF-K/DOQI clinical practice guidelines for vascular access: Update 2000. Am J Kidney Dis 2001; 37(1 Suppl 1): S137–81.

[No authors listed.] IV. NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney disease: Update 2000 [Published erratum appears in Am J Kidney Dis 2001; 38: 442]. Am J Kidney Dis 2001; 37(1 Suppl 1): S182–238.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1–266.

National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(4 Suppl 3): S1–201.

Kidney Disease Outcomes Quality Initiative (K/DOQI) Group. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003; 41(4 Suppl 3): S1–91.

Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43(5 Suppl 1): S1–290.

K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45(4 Suppl 3): S1–153.

Strippoli G.F. , Craig J.C. , Schena F.P. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004; 15: 411–19.

Besarab A. , Bolton W.K. , Browne J.K. , Egrie J.C. , Nissenson A.R. , Okamoto D.M. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584–90.

Paniagua R. , Amato D. , Vonesh E. , Correa-Rotter R. , Ramos A. , Moran J. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307–20.

Eknoyan G. , Beck G.J. , Cheung A.K. , Daugirdas J.T. , Greene T. , Kusek J.W. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010–19.

Wanner C. , Krane V. , Marz W. , Olschewski M. , Mann J.F. , Ruf G. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238–48.

Genzyme Corporation. Genzyme announces positive results from DCOR trial favoring use of Renagel. 28-7-2005. Available at: http://www.renagel.com/docs/DCOR_07_28_05.pdf

Fissell R.B. , Bragg-Gresham J.L. , Gillespie B.W. , Goodkin D.A. , Bommer J. , Saito A. International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 293–9.